C-reactive protein and pulmonary tuberculosis: What correlation with disease severity Source: International Congress 2015 – Management of TB: a patient focus Year: 2015
Serum cytokines level can differentiate active pulmonary tuberculosis from latent TB Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013
Association of serum cytokines with pulmonary tuberculosis treatment outcomes Source: International Congress 2014 – Tuberculosis: diagnosis Year: 2014
Serum paraoxonase activity and oxidative status in pediatric patients with pulmonary tuberculosis Source: International Congress 2014 – Respiratory infections in children Year: 2014
Differential microRNA expression in plasma of patients with pulmonary tuberculosis Source: International Congress 2015 – Latest news on miRNAs in pulmonary research Year: 2015
The change in serum Ca 19-9 levels according to treatment responses in pulmonary nontuberculous mycobacterial disease Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology Year: 2015
The diagnostic value of serum soluble CD 14 and IL-10 levels in newly diagnosed pulmonary tuberculosis patients and the relationship with disease extensity Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013
System of matrix metalloproteinases in infiltrative pulmonary tuberculosis (with and without lung tissue destruction) Source: International Congress 2015 – Biomarkers in TB: immunology and physiology Year: 2015
Vitamin D levels in patients with a clinical diagnosis of tuberculosis Source: Annual Congress 2013 –Tuberculosis susceptibility: genetic polymorphism and vitamin D deficiency Year: 2013
Multiplexed cytokine and chemokine profiling in patients with latent tuberculosis infection: Treatment effect Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014
Biomarkers of systemic inflammatory response in patients with tuberculosis, combined with HIV infection Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016
Decreased miR-150-5p and miR-23a-3p expressions in patients with active Pulmonary Tuberculosis (TB) disease Source: International Congress 2019 – Tuberculosis: from basic science to patient care Year: 2019
Utility of mycobacterium tuberculosis Rv0081-specific host gene expression to distinguish latent infection from active tuberculosis disease Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016
Diagnosing latent tuberculosis in immunocompromised patients measuring blood IP-10 production capacity: An analysis of chronic renal faulire patients Source: International Congress 2015 – Screening strategies in TB Year: 2015
Markers of cellular immunity in the diagnosis of tuberculosis pleurisy Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016
Levels of cytokines, sCD31 and expression of CD38 in patients with bronchial asthma of various severity out of a disease exacerbation Source: International Congress 2014 – Biomarkers of asthma and clinical immunology Year: 2014
Analysis of the level of cytokines in blood serum and condensate in children with bronchopulmonary pathology Source: International Congress 2014 – Respiratory infections in children Year: 2014
Acute phase reaction in pulmonary tuberculosis during treatment Source: International Congress 2015 – Biomarkers in TB: immunology and physiology Year: 2015
Circulating matrix metalloproteinase-9 (MMP-9) is associated with the extension of lung disease in patients with active tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 35s Year: 2004
MMP-3 serum levels and MMP3 -1171insA promoter polymorphism in patients with COPD Source: International Congress 2014 – Basic and translational research in asthma and COPD Year: 2014